San Francisco, United States
ExcepGen, an early-stage biotechnology startup founded in 2018, is rapidly making its mark in the biopharma and healthcare sectors. Located in San Francisco, United States, the company is devoted to addressing fundamental challenges in drug discovery. With the ambitious slogan "Solving fundamental problems in drug discovery to create a new generation of therapeutics," ExcepGen focuses on pioneering solutions that drive the creation of novel therapeutics.
Recently, ExcepGen secured a $4.00M Seed Round investment on August 24, 2023, indicating robust early-stage traction and investor confidence. The investment was spearheaded by notable investors such as RA Capital Management, Apollo Projects, ZAKA VC, Oxonian Ventures, and the Gravity Fund.
ExcepGen holds significant potential for shaping future biopharmaceutical breakthroughs. Its strong focus on innovation in drug discovery positions it well within the competitive landscape of life sciences.
